Akadeum Life Sciences
Ann Arbor, US · Founded 2014 · Delaware corporation · 14 employees on LinkedIn · 14 known investors
Find your way into Akadeum Life Sciences
2 people in our graph can introduce you to the Akadeum Life Sciences team.
Sign up to see every warm intro you have to Akadeum Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Akadeum Life Sciences team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.
Founders & leadership
Akadeum Life Sciences was founded in 2014 by Kalyan Handique and John Younger.

Board





Investors · 14
How we know: Arboretum Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: Beringea's portfolio page · funding news · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: eLab Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Hemisphere Ventures LLC's portfolio page · Not right? Tell us
How we know: board seat on SEC Form D · funding news · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: Western Technology Investment's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$17.6M disclosed across 8 rounds · 2014–2026
▶$2.1MraisedJul 2026 · 9 investors · BiotechnologyRule 506(b)
- Kalyan HandiqueExecutive Officer, Director
- Paul D'AmatoDirector
- Jenni LiDirector
- James MilitelloExecutive Officer
- Offering amount
- $3.4M
- Amount sold
- $2.1M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.6MraisedApr 2025 · 35 investors · BiotechnologyRule 506(b)
- Jeffrey S. WilliamsDirector
- Paul D'AmatoDirector
- Dan KidleDirector
- Brandon McNaughtonExecutive Officer, Director
- James MilitelloExecutive Officer
- Offering amount
- $7.2M
- Amount sold
- $5.6M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedMay 2023 · 22 investors · BiotechnologyRule 506(b)
- William HyunDirector
- Brandon McNaughtonExecutive Officer, Director
- Dan KidleDirector
- George DunbarDirector
- John GavenonisDirector
- Offering amount
- $6.5M
- Amount sold
- $6M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedNov 2018 · Other Health CareRule 506(b)
- Brandon McNaughtonExecutive Officer, Director
- John YoungerExecutive Officer, Director
- Brock SiegelDirector
- Douglas NealDirector
- Offering amount
- $2M
- Amount sold
- $900K
- Minimum investment
- $25K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.5MraisedAug 2017 · 19 investors · Other Health CareRule 506(b)
- Paul BrownDirector
- John YoungerExecutive Officer, Director
- Brandon McNaughtonExecutive Officer, Director
- William WoodDirector
- Douglas NealDirector
- Offering amount
- $1.6M
- Amount sold
- $1.5M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$360KraisedDec 2016 · Other Health CareRule 506(b)
- John YoungerExecutive Officer, Director
- Douglas NealDirector
- Brandon McNaughtonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $360K
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$905.1KraisedAug 2015 · 3 investors · Other Health CareRule 506(b)
- Brandon McNaughtonExecutive Officer, Director
- Douglas NealDirector
- John YoungerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $905.1K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$150KraisedOct 2014 · 1 investors · Other Health CareRule 506(b)
- John YoungerExecutive Officer, Director
- Brandon McNaughtonExecutive Officer, Director
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Akadeum Life Sciences.
In the news
Frequently asked questions
- What does Akadeum Life Sciences do?
- Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.
- Who founded Akadeum Life Sciences?
- Akadeum Life Sciences was founded by Kalyan Handique, John Younger in 2014.
- Who are Akadeum Life Sciences's investors?
- Akadeum Life Sciences's investors include Arboretum Ventures, Beringea, Berkeley Catalyst, BlueStone Venture Partners, CANTILEVER INVESTORS, eLab Ventures, Hemisphere Ventures LLC, ID Ventures and 6 more.
- How much funding has Akadeum Life Sciences raised?
- Akadeum Life Sciences has disclosed $17.6M raised across 8 rounds.
- Where is Akadeum Life Sciences headquartered?
- Akadeum Life Sciences is headquartered in Ann Arbor, US.










